Chengsen Jia

Dr. Chengsen Jia


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2024 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
TYTing Yang
Ting Yang
WLWentao Liu
Wentao Liu
JHJiali He
Jiali He
CGChenfan Gui
Chenfan Gui
LMLijiao Meng
Lijiao Meng
CJChengsen Jia
Chengsen Jia
Background: Non-invasive brain stimulation (NIBS) combined with cognitive training (CT) may have shown some prospects on improving cognitive function in patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI). However, data from clinical trials or meta-analysis involving NIBS combined with CT have shown controversial results. The aim of this systematic review and meta-analysis was to evaluate short-term and long-term effects of NIBS combined with CT on improving global cognition and other specific cognitive domains in patients with AD and MCI. Methods: This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Five electronic databases including PubMed, Web of Science, EBSCO, Cochrane Library and Embase were searched up from inception to 20 November 2023. The PEDro scale and the Cochrane’s risk of bias assessment were used to evaluate risk of bias and methodological quality of included studies. All statistical analyses were conducted with Review Manager 5.3. Results: We included 15 studies with 685 patients. The PEDro scale was used to assess methodological quality with a mean score of 7.9. The results of meta-analysis showed that NIBS combined with CT was effective on improving global cognition in AD and MCI (SMD = 0.52, 95% CI (0.18, 0.87), p = 0.003), especially for patients accepting repetitive transcranial magnetic stimulation (rTMS) combined with CT (SMD = 0.46, 95% CI (0.14, 0.78), p = 0.005). AD could achieve global cognition improvement from NIBS combined with CT group (SMD = 0.77, 95% CI (0.19, 1.35), p = 0.01). Transcranial direct current stimulation (tDCS) combined with CT could improve language function in AD and MCI (SMD = 0.29, 95% CI (0.03, 0.55), p = 0.03). At evaluation follow-up, rTMS combined with CT exhibited larger therapeutic responses to AD and MCI in global cognition (SMD = 0.55, 95% CI (0.09, 1.02), p = 0.02). AD could achieve global cognition (SMD = 0.40, 95% CI (0.03, 0.77), p = 0.03) and attention/working memory (SMD = 0.72, 95% CI (0.23, 1.20), p = 0.004) improvement after evaluation follow-up from NIBS combined with CT group. Conclusions: Overall, NIBS combined with CT, particularly rTMS combined with CT, has both short-term and follow-up effects on improving global cognition, mainly in patients with AD. tDCS combined with CT has advantages on improving language function in AD and MCI. Future more studies need evaluate cognitive effects of NIBS combined with CT on other specific cognitive domain in patients with cognitive deterioration.

30 October 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YMYouda Meng
Youda Meng
LZLiang Zhou
Liang Zhou
YXYong Xia
Yong Xia
CJChengsen Jia
Chengsen Jia
LHLiyi Huang
Liyi Huang
Tumor hypoxia represents a fundamental barrier to effective cancer therapy, driving resistance to chemotherapy, radiotherapy, and immunotherapy while fostering invasion and metastasis. Hyperbaric oxygen therapy (HBOT), by substantially increasing dissolved oxygen in plasma, offers a unique approach to reoxygenate tumors and remodel the tumor microenvironment. Preclinical and clinical studies have revealed that HBOT enhances drug penetration, augments radiation-induced DNA damage, alleviates hypoxia-driven immunosuppression, and synergizes with immune checkpoint blockade. At the mechanistic level, HBOT modulates oxidative stress, ferroptosis, angiogenesis, and cancer stem cell maintenance, thereby counteracting hallmarks of therapeutic resistance. Despite these promising findings, controversies remain regarding its dose-response relationship, long-term safety, and the potential for pro-angiogenic effects under certain conditions. Advances in multi-omics profiling, precision imaging, and adaptive trial designs are expected to define optimal treatment parameters and identify predictive biomarkers. We propose that integrating HBOT into multimodal oncologic regimens could overcome hypoxia-associated resistance and improve patient outcomes. Positioned at the intersection of basic mechanisms and clinical translation, HBOT is poised to reshape strategies for personalized cancer therapy.

26 February 2025 in Sensors
Verified
Journal Article
Open access
PDF file
QWQiang Wu
Qiang Wu
MQMengli Qiu
Mengli Qiu
XLXiaomei Liu
Xiaomei Liu
AHAaron Wan Jia He
Aaron Wan Jia He
TYTing Yang
Ting Yang
CJChengsen Jia
Chengsen Jia
The management of Parkinson’s disease (PD) has increasingly focused on innovative technologies, particularly virtual reality (VR), which has emerged as a significant tool for addressing neurological disorders. This bibliometric analysis summarizes current research trends and hotspots regarding VR applications in PD management. A comprehensive search of the Science Citation Index Expanded (SCIE) within the Web of Science Core Collection (WoSCC) identified 475 publications from 2000 to 2024. Key findings indicate a substantial increase in publication output, especially after 2013, driven by technological advancements and investments from major IT companies. Prominent research institutions and scholars from Australia, Israel, Italy, and Spain have led this field, exploring various VR applications for PD patients. The focus of VR therapy research has evolved from primarily addressing freezing of gait (FOG) to a broader range of functional impairments, including balance, postural control, upper limb motor, and cognitive function. This study provides valuable insights into the evolving landscape of clinical research on VR in PD management, highlighting global trends and potential areas for future investigation and application of VR therapies.

25 May 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HMHui Ma
Hui Ma
KZKehong Zhao
Kehong Zhao
CHChenggong Hu
Chenggong Hu
CHCheng Huang
Cheng Huang
XHXianrui Hu
Xianrui Hu
CJChengsen Jia
Chengsen Jia
This study aimed to investigate the safety and feasibility of transcranial direct current stimulation (tDCS) in patients with acute disorders of consciousness (DoC), and to preliminarily explore its potential intervention effects. In this sham-controlled randomized trial, participants with acute DoC within 7–28 days post-onset were randomly assigned (1:1) to either the active or sham stimulation group. The active-stimulation group received 2-mA direct current stimulation at the left dorsolateral prefrontal cortex (DLPFC) for 20 min per session, twice daily, over 10 consecutive working days. Primary outcomes were safety and feasibility. Exploratory efficacy outcomes included the Coma Recovery Scale-Revised (CRS-R), Glasgow Coma Scale (GCS), and Full Outline of UnResponsiveness (FOUR) scale, assessed at baseline, after 5 days, and upon completion of the intervention. Between May 2022 and May 2023, 22 eligible patients were enrolled and randomly assigned to the active (n = 11) or sham (n = 11) group. All participants completed the full protocol without dropouts. No severe adverse events were reported; transient skin redness occurred in six patients (54.55%) in the active-stimulation group. After 10 days, the active-stimulation group showed significantly higher scores on exploratory neurobehavioral measures (CRS-R: 15.91 ± 6.56 vs. 7.64 ± 5.22, t = 3.27, p < 0.01; FOUR: 13.73 ± 2.97 vs. 9.36 ± 4.65, t = 2.62, p = 0.01). Compared with sham stimulation, the tDCS protocol demonstrated favorable safety and feasibility in patients with acute DoC, with preliminary signals of neurobehavioral improvement. These findings support the conduct of larger, adequately powered trials to confirm therapeutic efficacy. Trial registration This trial was prospectively registered in the Chinese Clinical Trial Registry (identifier: ChiCTR2200060209) on 22-05-22.

1 August 2024 in Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
TYTing Yang
Ting Yang
JHJiali He
Jiali He
LSLinlin Song
Linlin Song
WLWentao Liu
Wentao Liu
CGChenfan Gui
Chenfan Gui
CJChengsen Jia
Chengsen Jia
Objective To explore the application value of the patient version of general practitioner assessment of cognition (P-GPCOG) for screening elderly with mild cognitive impairment (MCI) in community. Methods A total of 905 elderly were recruited from West China Tianfu Hospital, Sichuan University and Chongzhou Second Hospital from April 2022 to November 2023, including 627 cases in normal cognitive function group (NC group) and 278 cases in MCI group. The cognitive function of the subjects was evaluated by P-GPCOG, the Montreal Cognitive Assessment (MoCA), and the 8-item ascertain dementia (AD8). The independence of daily living ability was evaluated by the Lawton Instrumental Activities of Daily Living Scale (IADLs). The Geriatric Depression Scale-15 (GDS-15) was used to assess the depressive symptoms of the subjects. The receiver operating characteristic (ROC) curve was drawn, and the area under the curve (AUC), sensitivity, specificity, positive predictive value and negative predictive value were calculated to evaluate the application value of GPCOG screening. Results Compared with the NC group, the MoCA and Lawton-IADL scores were significantly lower in the MCI group (P<0.001, P=0.022). The AD8 and GDS-15 scores were significantly higher (P<0.001). There was a significant difference in the P-GPCOG scores between the two groups (Z=15.001, P<0.001). Compared with the NC group, correct rate of the time orientation, clock drawing, reporting events and delayed recall, and the total score were significantly lower in the MCI group, with statistically significant differences (P<0.001). In the MCI group, the order of cognitive impairment rate from high to low was delayed recall test, clock drawing test, time orientation and reporting events. AUC of P-GPCOG for differentiating MCI patients was 0.804 [95% CI (0.773, 0.836), P<0.001], with an optimal cutoff value of 7/8 points. The sensitivity was 82.7%, the specificity was 72.6%, the positive predictive value was 57.2%, and the negative predictive value was 90.4%. Conclusion The P-GPCOG is a good community-based cognitive screening tool for screening MCI patients in community, but its original scoring criteria needs to be refined to improve the correct screening rate.

1 August 2024 in Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
KZKun Zheng
Kun Zheng
HYHaolun Yang
Haolun Yang
CJChengsen Jia
Chengsen Jia
LZLiming Zhang
Liming Zhang
Objective To observe the effects of muscle energy technology (MET) combined with conventional rehabilitation trerapy on patients with chronic non-specific neck pain (CNSNP). Methods A total of 54 patients with CNSNP in the outpatient department of rehabilitation medical center of West China Hospital, Sichuan University from May 2022 to March 2023 were randomly divided into control group and observation group, with 27 cases in each group. During the course of treatment, three cases withdrew from the study due to poor compliance, including two cases in the control group and one case in the observation group. Finally 25 and 26 cases were included in the control group and the observation group, respectively. The control group received conventional rehabilitation trerapy (physical modality therapy and exercise training) combined with stretching training. Physical modality therapy mainly included magnetothermal therapy and medium frequency pulsed electrotherapy, with a duration of 20 minutes a time for each treatment, once a day, continuous treatment, and three times a week; exercise training included isometric contraction training and deep neck flexor muscle group training, with three times a day, continuous treatment, and three times a week; stretching training were performed once a day, continuous treatment, and three times a week. The observation group received MET therapy in addition to the conventional rehabilitation therapy in the control group. The therapist stretched the target muscle to the position where pain was triggered or the resistance point of soft tissue could be felt, fixed the starting and ending points of the muscle with both hands, applied moderate resistance, and allowed the patient's target muscle to perform isometric contraction (an intensity of 20% of the maximum force) and relax after 10 seconds, and then continued to stretch the target muscle and reached the position of the next resistance point, taking the resistance point as the starting position, repeated the procedure 3 to 5 times, once a day, three times a week, lasting for one week. Before treatment and one week after treatment, visual analog scale (VAS) was used to assess the pain level; neck disability index (NDI) was used to evaluate cervical spine dysfunction; Yasuhisa Tanaka cervical spondylotic radiculopathy 20 (CSR20) was used to evaluate cervical spine function; "Clinical practice guideline for physical therapy assessment and treatment in patients with nonspecific neck pain" were used to evaluate the clinical efficacy; the adverse reaction such as aggravation of neck pain, nausea, vomiting, dizziness, increased heart rate, etc. that occurred during treatment were observed. Results Compared with that before treatment, VAS scores and NDI index decreased significantly of both groups after treatment (P<0.05), CSR20 score increased significantly, and the differences were statistically significant (P<0.05). Compared with the control group, VAS score was significantly lower in the observation group after treatment, CSR20 score was significantly higher, and the differences were statistically significant (P<0.05). The effective rate in the observation group (92.31%) was higher than that of the control group (28.00%), and the difference was statistically significant (P<0.05). During the course of treatment, there were no adverse reactions in both groups. Conclusion MET combined with conventional rehabilitation therapy can effectively improve the pain and cervical spine function of patients with CNSNP, which is recommended for clinical promotion and application.